This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cerchiari, E. L. Articles by Sclabassi, R. J. Search for Related Content PubMed PubMed Citation Articles by Cerchiari, E. L. Articles by Sclabassi, R. J.

Stroke, Vol 18, 869-878, Copyright © 1987 by American Heart Association

ARTICLES

Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs

EL Cerchiari, TM Hoel, P Safar and RJ Sclabassi

Oxygen free radicals generated during reoxygenation after cardiac arrest may impair recovery of cerebral blood flow and function. In a randomized study in vivo, we tested the following anti-free radical combination therapy administered at the beginning of cardiopulmonary resuscitation after apnea-induced cardiac arrest of 7 minutes: 1) ventilation with 100% nitrogen for 30 seconds to allow the delivery of therapy before oxygen, 2) 10 mg/kg i.a. superoxide dismutase followed by 10 mg/kg i.v. over 1 hour to scavenge the superoxide anion radical, and 3) 20 mg/kg i.v. deferoxamine over 1 hour to prevent membrane lipid peroxidation. We evaluated the effects of this combined treatment on the recovery of cardiovascular variables, cerebral blood flow and oxygen consumption, and somatosensory evoked potentials in 20 dogs 6 hours after resuscitation. Compared with standard treatment (n = 10), the combined treatment (n = 10) did not affect cardiovascular variables, significantly mitigated cerebral blood flow changes after cardiac arrest, and enhanced recovery of somatosensory evoked potentials. We conclude that oxygen free radicals play a role in the pathogenesis of the arrest-related derangements of cerebral blood flow and function that are effectively reduced by this combined treatment; we recommend evaluation of its components in outcome studies.

This article has been cited by other articles:

				T. Kondo, A. G. Reaume, T.-T. Huang, E. Carlson, K. Murakami, S. F. Chen, E. K. Hoffman, R. W. Scott, C. J. Epstein, and P. H. Chan Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia J. Neurosci., June 1, 1997; 17(11): 4180 - 4189. [Abstract] [Full Text] [PDF]

				R. Kothari, W. Barsan, T. Brott, J. Broderick, and S. Ashbrock Frequency and Accuracy of Prehospital Diagnosis of Acute Stroke Stroke, June 1, 1995; 26(6): 937 - 941. [Abstract] [Full Text]

				H. Caner, S. Senaati, H. Bolay, K. Kilinc, and K. Benli Protective Effect of the Iron Chelator Deferoxamine on Cerebral Vasospasm Vascular and Endovascular Surgery, October 1, 1992; 26(8): 665 - 671. [Abstract] [PDF]

				J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF]